Target intelligence / Profile preview

Innate pattern-recognition receptor (PRR) (PRR)

Target
PRR
Molecular classification
Receptor, Innate immune sensor
01

Overview

Innate pattern-recognition receptors (PRRs) are a diverse class of germline-encoded host sensors that detect conserved molecular structures known as pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (Li et al., 2021, Signal Transduct Target Ther). These receptors, which include Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are primarily expressed by antigen-presenting cells such as dendritic cells and macrophages (Kawai & Akira, 2010, Nat Immunol). Upon activation by ligands—including vaccine adjuvants or residual motifs from pathogens—PRRs initiate signaling cascades that lead to the production of pro-inflammatory cytokines, type I interferons, and the maturation of the adaptive immune response (Reed et al., 2013, Nat Med). In the context of therapeutics, PRRs are targeted to enhance the efficacy of vaccines (as adjuvants) or to stimulate anti-tumor immunity in oncology (Kawai & Akira, 2011, Immunity). Conversely, dysregulated PRR signaling is implicated in chronic inflammatory and autoimmune disorders, making them targets for inhibitory drugs (Thompson et al., 2011, Mucosal Immunol).

Other names
Pattern recognition receptorsPRRsPathogen recognition receptorsInnate immune receptors
02

Mechanism of action

Agonism of PRRs to induce innate immune activation and enhance adaptive immunity; Antagonism of PRRs to suppress pathological inflammation.

03

Biological functions

Immune responseSignal transductionInflammationPathogen detectionApoptosis
04

Disease associations

InfectionCancerAutoimmune diseaseInflammatory disorder
05

Safety considerations

Systemic inflammatory response syndrome (SIRS)Cytokine release syndromeInduction of autoimmunityInjection site reactions
06

Interacting drugs

Monophosphoryl lipid A

7 more in the full profile.

07

Biomarkers

Tumor necrosis factor-alpha (TNF-alpha)Interleukin-6 (IL-6)Interleukin-1 beta (IL-1 beta)Type I Interferons (IFN-alpha/beta)CD80CD86

Beyond the preview

Go deeper on Innate pattern-recognition receptor (PRR) (PRR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate pattern-recognition receptor (PRR) (PRR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call